RT plus TMZ and ENZ; ENZ alone; TMZ and ENZ for Glioblastoma
This trial will test a new treatment for brain cancer. It will compare the new treatment to a placebo, and 300 people will be enrolled.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there any opportunities for new participants in this trial?
"As of right now, this study is not recruiting patients. The last time this information was updated was on October 11th, 2022. There are currently 458 clinical trials actively looking for participants with glioblastoma and 219 studies for RT plus TMZ and ENZ; ENZ alone; TMZ and ENZ actively admitting participants."
What are RT plus TMZ and ENZ; ENZ alone; TMZ and ENZ used to treat?
"The conventionally accepted treatment for nitrosourea is a combination of RT, TMZ, and ENZ. Additionally, this treatment can be used to manage a variety of other conditions including advance directives, refractory, advanced mycosis fungoides, and refractory neuroblastoma."
What are the risks associated with the combined use of RT, TMZ, and ENZ; ENZ alone; and TMZ and ENZ?
"This treatment, which is currently in Phase 3 clinical trials, has received a score of 3 for safety. This is due to the presence of both efficacy data and multiple rounds of safety data."
Are there other ongoing trials that study the combination of RT plus TMZ and ENZ, ENZ by itself, or TMZ and ENZ together?
"18,676 completed trials studying the effects of RT plus TMZ and ENZ; ENZ alone; and TMZ and ENZ have been completed since the initial 2002 study at Memorial Sloan Kettering Cancer Center. As of now, 219 trials are actively recruiting patients, with a high concentration of these clinical studies taking place in San Diego, California."
What makes this test group unique?
"Since 2002, researchers have been studying the effects of RT plus TMZ and ENZ; ENZ alone; and TMZ and ENZ. The first study was conducted in 2002 and was sponsored by Schering-Plough. After the initial trial, which involved 60 patients, RT plus TMZ and ENZ; ENZ alone; and TMZ and ENZ received its Phase 2 drug approval. Today, there are 219 active studies for RT plus TMZ and ENZ; ENZ alone; and TMZ and ENZ across 947 cities and 34 countries."